[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100600641":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":11,"locations":10,"responsibleParty":17,"collaborators":10,"id":19,"slug":20,"hasResults":21,"nctId":22,"briefTitle":23,"officialTitle":24,"acronym":10,"eligibilityCriteria":25,"healthyVolunteers":21,"sex":26,"minAge":10,"maxAge":10,"enrollmentInfo":27,"targetDuration":30,"studyType":31,"phases":10,"briefSummary":32,"conditions":33,"keywords":10,"overallStatus":35,"whyStopped":10,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":10},{"fullName":5,"class":6},"The Affiliated Hospital Of Guizhou Medical University","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":10},"Based on the patients' neurological functional outcomes, they were categorized into a good prognosis",null,[12],{"name":13,"role":14,"phone":15,"phoneExt":10,"email":16},"Qian Wu","CONTACT","18586876127","596914581@qq.com",{"type":18,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100600641","research-on-the-clinical-value-of-cranial-ct-and-cta-for-cerebral-hemorrhage-patients-100600641",false,"NCT07100132","Research on the Clinical Value of Cranial CT and CTA for Cerebral Hemorrhage Patients","Research on the Clinical Value of Cranial CT and CTA in Patients With Cerebral Hemorrhage","Inclusion Criteria:\n\n(1) Patients who were confirmed to have cerebral hemorrhage through head CT imaging examination upon admission; (2) Those who completed head CT and CTA within 8 hours of onset and had a follow-up CT within 24 hours of admission; (3) With complete clinical data.\n\nExclusion Criteria:\n\n(1) Patients who cannot complete CT and CTA within the prescribed time; (2) Patients with secondary cerebral hemorrhage due to cerebral vascular malformations, brain tumors, brain trauma, cerebral aneurysms, etc.; (3) Patients who have been taking oral anticoagulants for a long time or have blood system diseases; (4) Primary intraventricular hemorrhage.","ALL",{"count":28,"type":29},300,"ESTIMATED","6 Months","OBSERVATIONAL","The objective of this observational study is to investigate the predictive value of various imaging signs in patients with intracerebral hemorrhage, thereby providing a reference for clinical diagnosis and treatment. The primary aim is to evaluate the association between specific imaging signs and both hematoma expansion and poor outcomes in these patients.",[34],"Intracerebral Hemorrhage (ICH)","NOT_YET_RECRUITING","2025-07-27",{"date":38,"type":39},"2025-08-03","ACTUAL",{"date":41,"type":29},"2025-10-01",{"date":43,"type":29},"2027-06-01",{"name":5,"class":6}]